1. Home
  2. ABP vs ISRL Comparison

ABP vs ISRL Comparison

Compare ABP & ISRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • ISRL
  • Stock Information
  • Founded
  • ABP 2004
  • ISRL 2021
  • Country
  • ABP United States
  • ISRL United States
  • Employees
  • ABP N/A
  • ISRL N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • ISRL Blank Checks
  • Sector
  • ABP Health Care
  • ISRL Finance
  • Exchange
  • ABP Nasdaq
  • ISRL Nasdaq
  • Market Cap
  • ABP 78.8M
  • ISRL 144.2M
  • IPO Year
  • ABP N/A
  • ISRL 2023
  • Fundamental
  • Price
  • ABP $3.01
  • ISRL $11.32
  • Analyst Decision
  • ABP
  • ISRL
  • Analyst Count
  • ABP 0
  • ISRL 0
  • Target Price
  • ABP N/A
  • ISRL N/A
  • AVG Volume (30 Days)
  • ABP 1.9M
  • ISRL 3.9K
  • Earning Date
  • ABP 02-18-2025
  • ISRL 01-01-0001
  • Dividend Yield
  • ABP N/A
  • ISRL N/A
  • EPS Growth
  • ABP N/A
  • ISRL N/A
  • EPS
  • ABP N/A
  • ISRL 0.26
  • Revenue
  • ABP $122,000.00
  • ISRL N/A
  • Revenue This Year
  • ABP N/A
  • ISRL N/A
  • Revenue Next Year
  • ABP N/A
  • ISRL N/A
  • P/E Ratio
  • ABP N/A
  • ISRL $43.49
  • Revenue Growth
  • ABP N/A
  • ISRL N/A
  • 52 Week Low
  • ABP $0.95
  • ISRL $10.68
  • 52 Week High
  • ABP $13.00
  • ISRL $11.40
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • ISRL 51.27
  • Support Level
  • ABP N/A
  • ISRL $11.30
  • Resistance Level
  • ABP N/A
  • ISRL $11.40
  • Average True Range (ATR)
  • ABP 0.00
  • ISRL 0.02
  • MACD
  • ABP 0.00
  • ISRL -0.00
  • Stochastic Oscillator
  • ABP 0.00
  • ISRL 55.56

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.

About ISRL Israel Acquisitions Corp

Israel Acquisitions Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: